‹ ›
MYP_109993
← PREVIOUS NEXT → BACK
Basic Information
L12P
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antimicrobial ▸ Antifungal
Antiviral
Antiviral ▸ Anti-Herpesvirus ▸ Anti-HSV
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
12 amino acids
C64H99N23O17S
Standard
Sequence
LCLRNWDQGHRP
Physicochemical Analysis
1494.68 Da
8.26
0.84
0.57
0.0699
-1.29
0.66
-0.35
58.96
65.00
0.0833
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
666.38
-6.28
24.0
20.0
46.0
105.0
4.0
13.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0023822 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antifungal Antiviral
Candida albicans SC5314
PMID28883642;30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28883642/
RECORD: Rec_0037066 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HSV Replication inhibition
HSV-1 | Vero cells
50 μg/mL
% inhibition
Mammalian: 5.5 h; Yeast: 3 min; E. coli: 2 min
PaperAntiviral Activity of Synthetic Peptides Derived from Physiological Proteins. | Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C | Intervirology. 2018;61(4):166-173. | DOI:10.1159/000494354 | PMID:30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0052241 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HSV Replication inhibition
HSV-1 | Vero cells
10 μg/mL
% inhibition
Mammalian: 5.5 h; Yeast: 3 min; E. coli: 2 min
PaperAntiviral Activity of Synthetic Peptides Derived from Physiological Proteins. | Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C | Intervirology. 2018;61(4):166-173. | DOI:10.1159/000494354 | PMID:30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0064825 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antifungal Antiviral
Herpes simplex virus 1
PMID28883642;30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28883642/
RECORD: Rec_0095944 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
HSV-1:inhibition of viral replication in Vero cells , 84% inhibition at 50 μg/ml
78 %
Inhibition
PaperPubMed PMID: 30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
1 2 3 4 NEXT LAST
Showing 5 records on this page · Page 1 of 4